News
News

The latest updates from AFAR.

Board Member in the News: Steven Austad and TAME Trial in STRIA news

Mar 27
2019

Board Member in the News: Steven Austad and TAME Trial in STRIA news View MoreBACK

 

On March 25, 2019, STRIA News spotlighted AFAR expert Steven N. Austad, PhD in an article exploring geroscience as research path to help us live healthier, for longer. The article also explores the AFAR-managed Targeting Aging with Metformin (TAME) Trial.

Dr. Austad is AFAR’s Scientific Director and serves as co-PI of the Coordinating Center of the Nathan Shock Centers of Excellence in the Basic Biology of Aging of the National Institute of Aging, NIH.

Read the article—"Scientists Think They Can Offer Us More Healthy Years. Now What?’’—here.

 





View MoreBACK TO TOP